NCT01658722View on ClinicalTrials.gov

Retrieval of Patient Information After Discontinuation

TerminatedOBSERVATIONAL

Enrollment

169

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Alzheimer's Disease

Interventions

DRUG

Bapineuzumab

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

JANSSEN Alzheimer Immunotherapy Research & Development, LLC

INDUSTRY